IV Synercid
March 2000
Aventis is now marketing IV Synercid.
Synercid contains the two new streptogramin antibiotics...quinupristin and dalfopristin.
It will be used as a "last resort" in treating vancomycin-resistant Enterococcus faecium (VREF).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive